The University of Chicago Header Logo

Sotorasib dosing and incremental cost ineffectiveness - implications and lessons for stakeholders.

Sotorasib dosing and incremental cost ineffectiveness - implications and lessons for stakeholders. Nat Rev Clin Oncol. 2024 Jan 30.

View in: PubMed